Logotipo del repositorio
Logotipo del repositorio
 

Comportamiento clínico de pacientes con diabetes mellitus tipo II u obesidad ingresados por neumonía grave por sars-cov-2 a una unidad de cuidados intensivos de Barranquilla, Atlántico durante la primera ola de pandemia

Vista sencilla de ítem
datacite.rightshttp://purl.org/coar/access_right/c_16ec
dc.contributor.advisorGuevara Romero, Edwin
dc.contributor.authorDel Rio Sayas, Víctor Eduardo
dc.date.accessioned2023-05-18T13:57:56Z
dc.date.available2023-05-18T13:57:56Z
dc.date.issued2023
dc.description.abstractLa enfermedad por COVID-19 (enfermedad por coronavirus 2019) se ha conocido como una patología con presentación clínica heterogénea y es por lo cual se han estudiado predictores clínicos que puedan proporcionar pistas vitales con respecto a la planificación y asignación eficientes de recursos para cada paciente, además de las poblaciones en riesgo basado en la evidencia científica, como lo es el caso de grupos sociodemográficos específicos y morbilidades como la diabetes mellitus tipo II, la obesidad, la hipertensión Arterial y otras patologías cardiometabólicas. Objetivos: caracterizar el comportamiento de la neumonía grave por COVID-19 en pacientes con antecedentes de diabetes mellitus u obesidad ingresados a una unidad de cuidados intensivos en Barranquilla durante el segundo semestre del año 2020. Materiales y métodos: estudio descriptivo, retrospectivo de cohorte transversal y de carácter cuantitativo en pacientes con neumonía por SARS-CoV-2 confirmado por prueba de RT-PCR a través de muestra de hisopado nasofaríngeo de diferentes grupos etarios y género que ingresaron a una Unidad de Cuidados Intensivos de MiRed Barranquilla IPS, en Barranquilla (Colombia) desde el 1 de junio del 2020 al 31 de diciembre del 2020.spa
dc.description.abstractCOVID-19 disease (coronavirus disease 2019) has been known as a pathology with heterogeneous clinical presentation and that is why clinical predictors have been studied that can provide vital clues regarding the efficient planning and allocation of resources for each patient, in addition to the populations at risk based on scientific evidence, as is the case of specific sociodemographic groups and morbidities such as type II diabetes mellitus, obesity, arterial hypertension and other cardiometabolic pathologies. Objectives: characterize the clinical outcome of severe pneumonia by COVID-19 in patients with a history of diabetes mellitus or obesity admitted to an intensive care unit in Barranquilla during the second semester of 2020. Materials and Methods: descriptive, retrospective, cross-sectional cohort study of a quantitative nature in patients with SARS-CoV-2 pneumonia confirmed by RT-PCR test through a nasopharyngeal swab sample of different age groups and gender who were admitted to a unit. of intensive care of MiRed Barranquilla IPS, of Barranquilla (Colombia) from June 1, 2020 to December 31, 2020.eng
dc.format.mimetypepdf
dc.identifier.urihttps://hdl.handle.net/20.500.12442/12413
dc.language.isospa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias de la Saludspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionaleng
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCOVID-19spa
dc.subjectObesidadspa
dc.subjectDiabetes mellitusspa
dc.subjectUnidad de cuidados intensivosspa
dc.subjectNeumonía gravespa
dc.subjectObesityeng
dc.subjectIntensive care uniteng
dc.subjectSevere pneumoniaeng
dc.titleComportamiento clínico de pacientes con diabetes mellitus tipo II u obesidad ingresados por neumonía grave por sars-cov-2 a una unidad de cuidados intensivos de Barranquilla, Atlántico durante la primera ola de pandemiaspa
dc.type.driverinfo:eu-repo/semantics/other
dc.type.spaOtros
dcterms.referencesYang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med [Internet]. 2020 May;8(5):475–81. Available from: https://doi.org/10.1016/S2213-2600(20)30079-5eng
dcterms.referencesMinisterio de Salud De Colombia. COVID-19 en Colombia [Internet]. Instituto Nacional de Salud. 2020 [cited 2022 Nov 27]. p. 1. Available from: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspxspa
dcterms.referencesHuang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020 Jul;14(4):395–403. Available from: https://doi.org/10.1016/j.dsx.2020.04.018eng
dcterms.referencesWu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated with human respiratory disease in China. Nature [Internet]. 2020 Mar 12;579(7798):265–9. Available from: https://doi.org/10.1038/s41586-020-2008-3eng
dcterms.referencesUpadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a Disease. Med Clin North Am [Internet]. 2018 Jan;102(1):13–33. Available from: http://dx.doi.org/10.1016/j.mcna.2017.08.004eng
dcterms.referencesDi Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet [Internet]. 2016 Aug;388(10046):776–86. Available from: http://dx.doi.org/10.1016/S0140-6736(16)30175-1eng
dcterms.referencesPetrova D, Salamanca-Fernández E, Rodríguez Barranco M, Navarro Pérez P, Jiménez Moleón JJ, Sánchez M-J. La obesidad como factor de riesgo en personas con COVID-19: posibles mecanismos e implicaciones. Atención Primaria [Internet]. 2020 Aug;52(7):496–500. Available from: https://doi.org/10.1016/j.aprim.2020.05.003spa
dcterms.referencesStefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol [Internet]. 2020 Jul 23;16(7):341–2. Available from: http://dx.doi.org/10.1038/s41574-020-0364-6eng
dcterms.referencesPetrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ [Internet]. 2020 May 22;m1966. Available from: https://doi.org/10.1136/bmj.m1966eng
dcterms.referencesCaussy C, Wallet F, Laville M, Disse E. Obesity is Associated with Severe Forms of COVID‐19. Obesity [Internet]. 2020 Jul 21;28(7):1175–1175. Available from: http://dx.doi.org/10.1002/oby.22842eng
dcterms.referencesDiaz V, Martínez J, Toledo P, Pozo G, Ortega A, Rendón J, et al. Aspectos clínicos de la COVID-19 en pacientes diabéticos. Diabetes Int y Endocrinol [Internet]. 2020;12(1):11–6. Available from: https://doi.org/10.5281/zenodo.4379332spa
dcterms.referencesSaeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract [Internet]. 2019 Nov;157:107843. Available from: https://doi.org/10.1016/j.diabres.2019.107843eng
dcterms.referencesAlgarín-Lara H, Guevara-Romero E, Osorio-Rodríguez E, Patiño-Patiño J, Flórez García V, Tuesca R de J, et al. Factores relacionados con la neumonía bacteriana en pacientes con COVID-19 en una unidad de cuidados intensivos de Barranquilla, Colombia. Acta Colomb Cuid Intensivo [Internet]. 2022 Jun;22:S28–35. Available from: https://doi.org/10.1016/j.acci.2021.07.002spa
dcterms.referencesWorld Health Organization. Weekly epidemiological update on COVID-19 - 26 October 2022 [Internet]. World Health Organization. 2022 [cited 2022 Nov 28]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reportseng
dcterms.referencesCalle M, Mallqui M, Hinojosa M, Beingolea L. La situación del sobrepeso, obesidad y el impacto de la COVID-19 en los países andinos [Internet]. Organismo Andino de Salud – Convenio Hipólito Unanue. 2022 [cited 2022 Nov 28]. Available from: https://orasconhu.org/es/node/1996spa
dcterms.referencesIDF. 463 millones de personas viven en el mundo padeciendo diabetes. International Diabetes Federation [Internet]. 2020; Available from: https://www.idf.org/our-network/regions-members/south-and-central-america/south-and-central-america-news/349:463-millones-de-personas-viven-en-el-mundo-padeciendo-diabetes.htmlspa
dcterms.referencesMinisterio de Salud De Colombia. Celebración del Día Mundial de la Diabetes y su Correspondiente Semana. [Internet]. Ministerio de salud y proteccion social. 2022 [cited 2022 Nov 28]. Available from: https://www.minsalud.gov.co/salud/Paginas/Semana-de-la-Diabetes.aspxspa
dcterms.referencesAschner P. Epidemiología de la diabetes en Colombia. Av en Diabetol [Internet]. 2010 Apr;26(2):95–100. Available from: https://doi.org/10.1016/S1134-3230(10)62005-4spa
dcterms.referencesLima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 y diabetes mellitus: una relación bidireccional. Clínica e Investig en Arterioscler [Internet]. 2021 May;33(3):151–7. Available from: https://doi.org/10.1016/j.arteri.2020.10.001spa
dcterms.referencesTorres-Tamayo M, Caracas-Portillo NA, Peña-Aparicio B, Juárez-Rojas JG, Medina-Urrutia AX, Martínez-Alvarado MR. Infección por coronavirus en pacientes con diabetes. Arch Cardiol México [Internet]. 2021 Sep 30;90(91). Available from: https://doi.org/10.24875/acm.m20000068spa
dcterms.referencesGuo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev [Internet]. 2020 Oct 7;36(7). Available from: https://doi.org/10.1002/dmrr.3319eng
dcterms.referencesCampoverde Espinoza RA, Vargas Olalla VP, Correa Muñiz LS. Evaluación y pronóstico de muerte en pacientes obesos con ventilación mecànica. MQRInvestigar [Internet]. 2022 Oct 23;6(4):420–37. Available from: https://doi.org/10.56048/MQR20225.6.4.2022.420-437spa
dcterms.referencesWatanabe M, Risi R, Tuccinardi D, Baquero CJ, Manfrini S, Gnessi L. Obesity and SARS-CoV-2: A population to safeguard. Diabetes Metab Res Rev [Internet]. 2020 Oct 11;36(7). Available from: https://doi.org/10.1002/dmrr.3325eng
dcterms.referencesPopkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships. Obes Rev [Internet]. 2020 Nov 26;21(11). Available from: https://doi.org/10.1111/obr.13128eng
dcterms.referencesJibrin YB, Okwong OK, Maigari IM, Dunga JA, Ballah AM, Umar MS, et al. Clinical and laboratory characteristics of COVID-19 among adult patients admitted to the isolation centre at Abubakar Tafawa Balewa Teaching Hospital Bauchi, Northeast Nigeria. Pan Afr Med J [Internet]. 2020;37(Suppl 1):27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33456651eng
dcterms.referencesHu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol [Internet]. 2021 Mar 6;19(3):141–54. Available from: https://doi.org/10.1038/s41579-020-00459-7eng
dcterms.referencesHelmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med [Internet]. 2020 Apr 24;9(4):1225. Available from: https://doi.org/10.3390/jcm9041225eng
dcterms.referencesHaider N, Rothman-Ostrow P, Osman AY, Arruda LB, Macfarlane-Berry L, Elton L, et al. COVID-19—Zoonosis or Emerging Infectious Disease? Front Public Heal [Internet]. 2020 Nov 26;8. Available from: https://doi.org/10.3389/fpubh.2020.596944eng
dcterms.referencesBryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, et al. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol [Internet]. 2021 Aug 1;34(8):1456–67. Available from: https://doi.org/10.1038/s41379-021-00793-yeng
dcterms.referencesSalazar M, Barochiner J, Espeche W, Ennis I. COVID-19, hipertensión y enfermedad cardiovascular. Hipertens y Riesgo Vasc [Internet]. 2020 Oct;37(4):176–80. Available from: https://doi.org/10.1016/j.hipert.2020.06.003eng
dcterms.referencesFernández García L, Puentes Gutiérrez AB, García Bascones M. Relación entre obesidad, diabetes e ingreso en UCI en pacientes COVID-19. Med Clin (Barc) [Internet]. 2020 Oct;155(7):314–5. Available from: https://doi.org/10.1016/j.medcli.2020.06.009spa
dcterms.referencesFantin R, Brenes-Camacho G, Barboza-Solís C. Defunciones por COVID-19: distribución por edad y universalidad de la cobertura médica en 22 países. Rev Panam Salud Pública [Internet]. 2021 Apr 28;45:1. Available from: https://doi.org/10.26633/RPSP.2021.42spa
dcterms.referencesFigueroa Triana JF, Salas Márquez DA, Cabrera Silva JS, Alvarado Castro CC, Buitrago Sandoval AF. COVID-19 y enfermedad cardiovascular. Rev Colomb Cardiol [Internet]. 2020 May;27(3):166–74. Available from: https://doi.org/10.1016/j.rccar.2020.04.004spa
dcterms.referencesLim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol [Internet]. 2021 Jan 13;17(1):11–30. Available from: https://doi.org/10.1038/s41574-020-00435-4eng
dcterms.referencesGazzaz ZJ. Diabetes and COVID-19. Open Life Sci [Internet]. 2021 Mar 25;16(1):297–302. Available from: https://doi.org/10.1515/biol-2021-0034eng
dcterms.referencesMcGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol [Internet]. 2021 Feb;9(2):82–93. Available from: https://doi.org/10.1016/S2213-8587(20)30405-8eng
dcterms.referencesChen J, Wu C, Wang X, Yu J, Sun Z. The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) [Internet]. 2020 Oct 5;11. Available from: https://doi.org/10.3389/fendo.2020.574541eng
dcterms.referencesPalacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, una emergencia de salud pública mundial. Rev Clínica Española [Internet]. 2021 Jan;221(1):55–61. Available from: https://doi.org/10.1016/j.rce.2020.03.001spa
dcterms.referencesLotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta [Internet]. 2020 Sep;508:254–66. Available from: https://doi.org/10.1016/j.cca.2020.05.044eng
dcterms.referencesVázquez JB, Menchén DA, Lloréns MMM, Moreno JS. Manifestaciones sistémicas y extrapulmonares en la COVID-19. Med - Programa Form Médica Contin Acreditado [Internet]. 2022 May;13(55):3235–45. Available from: https://doi.org/10.1016/j.med.2022.05.004spa
dcterms.referencesSanz JM, Gómez Lahoz AM, Martín RO. Papel del sistema inmune en la infección por el SARS-CoV-2: inmunopatología de la COVID-19. Med - Programa Form Médica Contin Acreditado [Internet]. 2021 May;13(33):1917–31. Available from: https://doi.org/10.1016/j.med.2021.05.005spa
dcterms.referencesBottino E, Ponce AA. Respuesta inmunitaria innata pulmonar en la infección por Sars-Cov-2. Rev Fac Cienc Med Cordoba [Internet]. 2022 Mar 7;79(1):33–42. Available from: https://doi.org/10.31053/1853.0605.v79.n1.30642spa
dcterms.referencesFormiga F, Tarazona-Santabalbina FJ. Diabetes y COVID-19 en el adulto mayor, simbiosis nociva. Rev Esp Geriatr Gerontol [Internet]. 2020 Nov;55(6):315–6. Available from: https://doi.org/10.1016/j.regg.2020.07.006eng
dcterms.referencesBellido V, Pérez A. Consecuencias de la COVID-19 sobre las personas con diabetes. Endocrinol Diabetes y Nutr [Internet]. 2020 Jun;67(6):355–6. Available from: https://doi.org/10.1016/j.endinu.2020.04.001spa
dcterms.referencesGil R, Bitar P, Deza C, Dreyse J, Florenzano M, Ibarra C, et al. CUADRO CLÍNICO DEL COVID-19. Rev Médica Clínica Las Condes [Internet]. 2021 Jan;32(1):20–9. Available from: https://doi.org/10.1016/j.rmclc.2020.11.004spa
dcterms.referencesYe Q, Wang B, Mao J, Fu J, Shang S, Shu Q, et al. Epidemiological analysis of COVID‐19 and practical experience from China. J Med Virol [Internet]. 2020 Jul 10;92(7):755–69. Available from: https://doi.org/10.1002/jmv.25813eng
dcterms.referencesRastad H, Ejtahed H-S, Mahdavi-Ghorabi A, Arzaghi M, Safari A, Shahrestanaki E, et al. Factors associated with the poor outcomes in diabetic patients with COVID-19. J Diabetes Metab Disord [Internet]. 2020 Dec 9;19(2):1293–302. Available from: https://doi.org/10.1007/s40200-020-00646-6eng
dcterms.referencesVila Muntadas M, Agustí Sunyer I, Agustí Garcia-Navarro A. Pruebas diagnósticas COVID-19: importancia del contexto clínico. Med Clin (Barc) [Internet]. 2021 Aug;157(4):185–90. Available from: https://doi.org/10.1016/j.medcli.2021.03.007spa
dcterms.referencesLanga LS, Sallent LV, Díez SR. Interpretación de las pruebas diagnósticas de la COVID-19. FMC - Form Médica Contin en Atención Primaria [Internet]. 2021 Mar;28(3):167–73. Available from: https://doi.org/10.1016/j.fmc.2021.01.005spa
dcterms.referencesCortés Rubio JA, Costa Zamora MP, Canals Aracil M, Pulgar Feio M, Mata Martínez A, Carrasco Munera A. Evaluación de la prueba diagnóstica de detección rápida de antígeno de covid-19 (Panbio Covid rapid test) en atención primaria. Med Fam Semer [Internet]. 2021 Nov;47(8):508–14. Available from: https://doi.org/10.1016/j.semerg.2021.06.001spa
dcterms.referencesFolgueira López MD. Use of the SARS-CoV-2 antigen detection test in nasopharyngeal swab for COVID-19 infection control. Rev Española Quimioter [Internet]. 2020 Nov 30;33(6):390–1. Available from: https://doi.org/10.37201/req/127.2020eng
dcterms.referencesGestoso-Pecellín L, García-Flores Y, González-Quintana P, Marrero-Arencibia JL. Recomendaciones y uso de los diferentes tipos de test para detección de infección por SARS-COV-2. Enfermería Clínica [Internet]. 2021 Feb;31:S40–8. Available from: https://doi.org/10.1016/j.enfcli.2020.10.001spa
dcterms.referencesCordova E, Lespada MI, Cecchini D, Nieto F, Palonski S, Badran M, et al. Evaluación de la respuesta de los anticuerpos IGG específicos contra SARS-CoV-2 en el personal de salud con el esquema completo de la vacuna Sputnik V (Gam-COVID-Vac). Vacunas [Internet]. 2022 May;23:S14–21. Available from: https://doi.org/10.1016/j.vacun.2022.01.008spa
dcterms.referencesAlgarín Lara H, Rodado Villa R, Aldana Roa MF, Osorio Rodríguez EL, Patiño Patiño JJ. Neumotórax espontáneo primario no asociado a ventilación mecánica invasiva en pacientes con neumonía por COVID-19. Presentación de 2 casos. Acta Colomb Cuid Intensivo [Internet]. 2022 Apr;22(2):149–53. Available from: https://doi.org/10.1016/j.acci.2021.03.002spa
dcterms.referencesMartínez Chamorro E, Díez Tascón A, Ibáñez Sanz L, Ossaba Vélez S, Borruel Nacenta S. Diagnóstico radiológico del paciente con COVID-19. Radiologia [Internet]. 2021 Jan;63(1):56–73. Available from: https://doi.org/10.1016/j.rx.2020.11.001spa
dcterms.referencesAshtari S, Vahedian-Azimi A, Shojaee S, Pourhoseingholi MA, Jafari R, Bashar FR, et al. Características en tomografía computarizada de la neumonía por coronavirus-2019 (COVID-19) en tres grupos de pacientes iraníes: estudio de un solo centro. Radiologia [Internet]. 2021 Jul;63(4):314–23. Available from: s://doi.org/10.1016/j.rx.2021.03.002eng
dcterms.referencesFernández-Pérez GC, Oñate Miranda M, Fernández-Rodríguez P, Velasco Casares M, Corral de la Calle M, Franco López Á, et al. SARS-CoV-2: cómo es, cómo actúa y cómo se expresa en la imagen. Radiologia [Internet]. 2021 Mar;63(2):115–26. Available from: https://doi.org/10.1016/j.rx.2020.10.006spa
dcterms.referencesLópez Zúñiga D, López Zúñiga MÁ. El diagnóstico COVID-19 a través de la imagen. Med Clin (Barc) [Internet]. 2020 Aug;155(3):140. Available from: https://doi.org/10.1016/j.medcli.2020.04.006spa
dcterms.referencesCalvo I, SantaCruz-Calvo S, Aranzana MG, Mármol P, Luque JÁ, Peral I, et al. Tomografía digital y COVID-19: un avance en la valoración de opacidades pulmonares. Arch Bronconeumol [Internet]. 2020 Nov;56(11):761–3. Available from: https://doi.org/10.1016/j.arbres.2020.06.017spa
dcterms.referencesWorld Health Organization. WHO COVID-19 case definition [Internet]. World Health Organization. 2020 [cited 2022 Nov 28]. Available from: https://apps.who.int/iris/handle/10665/333912eng
dcterms.referencesMarta-Enguita J, Corroza-Laviñeta J, Ostolaza A. Factores de riesgo y predictores de gravedad en pacientes hospitalizados por COVID-19: análisis de 52 casos. Med Clin (Barc) [Internet]. 2020 Oct;155(8):360–1. Available from: https://doi.org/10.1016/j.medcli.2020.06.012spa
dcterms.referencesTarazona-Santabalbina FJ, de la Cámara de las Heras JM, Vidán MT, García Navarro JA. Enfermedad por coronavirus 2019 (COVID-19) y edadismo: revisión narrativa de la literatura. Rev Esp Geriatr Gerontol [Internet]. 2021 Jan;56(1):47–53. Available from: https://doi.org/10.1016/j.regg.2020.08.002spa
dcterms.referencesSalinas-Aguirre JE, Sánchez-García C, Rodríguez-Sánchez R, Rodríguez-Muñoz L, Díaz-Castaño A, Bernal-Gómez R. Características clínicas y comorbilidades asociadas a mortalidad en pacientes con COVID-19 en Coahuila (México). Rev Clínica Española [Internet]. 2022 May;222(5):288–92. Available from: https://doi.org/10.1016/j.rce.2020.12.006spa
dcterms.referencesNassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, et al. Diabetes Mellitus and COVID-19: Review Article. Diabetes Metab Syndr Clin Res Rev [Internet]. 2021 Nov;15(6):102268. Available from: https://doi.org/10.1016/j.dsx.2021.102268eng
dcterms.referencesSen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases [Internet]. 2021 Oct 6;9(28):8327–39. Available from: https://doi.org/10.12998/wjcc.v9.i28.8327eng
dcterms.referencesBretón I, de Hollanda A, Vilarrasa N, Rubio Herrera MA, Lecube A, Salvador J, et al. Obesidad y COVID-19. Un posicionamiento necesario. Endocrinol Diabetes y Nutr [Internet]. 2021 Oct;68(8):573–6. Available from: https://doi.org/10.1016/j.endinu.2021.02.001spa
dcterms.referencesKatsiki N, Gómez‐Huelgas R, Mikhailidis DP, Pérez‐Martínez P. Narrative review on clinical considerations for patients with diabetes and COVID‐19: More questions than answers. Int J Clin Pract [Internet]. 2021 Nov 21;75(11). Available from: https://doi.org/10.1111/ijcp.14833eng
dcterms.referencesRichardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA [Internet]. 2020 May 26;323(20):2052. Available from: https://doi.org/10.1001/jama.2020.6775eng
dcterms.referencesAlberti A, Schuelter-Trevisol F, Iser Betine PM, Traebert E, Freiberger V, Ventura L, et al. Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken. World J Clin Cases [Internet]. 2021 Jul 16;9(20):5358–71. Available from: https://doi.org/10.12998/wjcc.v9.i20.5358eng
dcterms.referencesHendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19. Circulation [Internet]. 2021 Jan 12;143(2):135–44. Available from: https://doi.org/10.1161/CIRCULATIONAHA.120.051936eng
dcterms.referencesJin S, Hu W. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Front Endocrinol (Lausanne) [Internet]. 2021 Apr 30;12. Available from: https://doi.org/10.3389/fendo.2021.602735eng
dcterms.referencesNg WH, Tipih T, Makoah NA, Vermeulen J-G, Goedhals D, Sempa JB, et al. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. Griffin DE, editor. MBio [Internet]. 2021 Feb 23;12(1). Available from: https://doi.org/10.1128/mBio.03647-20eng
dcterms.referencesZhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev [Internet]. 2021 Feb 20;37(2). Available from: https://doi.org/10.1002/dmrr.3377eng
dcterms.referencesAbad CL, Sandejas JCM, Poblete JB, Malundo AFG, Salamat MSS, Alejandria MM. Bacterial Co-infection and Antimicrobial Use Among Patients with COVID-19 Infection in a Referral Center in the Philippines: A Retrospective Cohort Study. IJID Reg [Internet]. 2022 Jul; Available from: https://doi.org/10.1016/j.ijregi.2022.07.003eng
dcterms.referencesYan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care [Internet]. 2020 Apr 27;8(1):e001343. Available from: https://doi.org/10.1136/bmjdrc-2020-001343eng
dcterms.referencesWu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA [Internet]. 2020 Apr 7;323(13):1239. Available from: https://doi.org/10.1001/jama.2020.2648eng
dcterms.referencesde Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, et al. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr [Internet]. 2020 Dec 31;12(1):75. Available from: https://doi.org/10.1186/s13098-020-00586-4eng
dcterms.referencesHehar J, Todter E, Lahiri SW. Association of Patient Characteristics, Diabetes, BMI, and Obesity With Severe COVID-19 in Metropolitan Detroit, MI. Clin Diabetes [Internet]. 2022 Apr 1;40(2):141–52. Available from: https://doi.org/10.2337/cd21-0065eng
dcterms.referencesAlgarin-Lara H, Osorio-Rodríguez E, Patiño-Patiño J, Solano-Ropero J, Rodado-Villa R. Hipercapnia refractaria en paciente con síndrome de obesidad-hipoventilación maligno y COVID-19. Reporte de caso y propuesta de manejo. Acta Colomb Cuid Intensivo [Internet]. 2022 Jun;22:S117–22. Available from: https://doi.org/10.1016/j.acci.2021.09.005spa
dcterms.referencesGao F, Zheng KI, Wang X-B, Sun Q-F, Pan K-H, Wang T-Y, et al. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care [Internet]. 2020 Jul;43(7):e72–4. Available from: https://doi.org/10.2337/dc20-0682eng
dcterms.referencesLighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis [Internet]. 2020 Jul 28;71(15):896–7. Available from: https://doi.org/10.1093/cid/ciaa415eng
dcterms.referencesSmati S, Tramunt B, Wargny M, Caussy C, Gaborit B, Vatier C, et al. Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study. Diabetes, Obes Metab [Internet]. 2021 Feb 6;23(2):391–403. Available from: https://doi.org/10.1111/dom.14228eng
dcterms.referencesPalaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism [Internet]. 2020 Jul;108:154262. Available from: https://doi.org/10.1016/j.metabol.2020.154262eng
dcterms.referencesSahin I, Haymana C, Demir T, Demirci I, Tasci I, Atmaca A, et al. Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity). Exp Clin Endocrinol Diabetes [Internet]. 2022 Feb 12;130(02):115–24. Available from: https://doi.org/10.1055/a-1552-4449eng
dcterms.referencesDixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med [Internet]. 2018 Sep 2;12(9):755–67. Available from: https://doi.org/10.1080/17476348.2018.1506331eng
dcterms.referencesHonce R, Karlsson EA, Wohlgemuth N, Estrada LD, Meliopoulos VA, Yao J, et al. Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains. Moscona A, editor. MBio [Internet]. 2020 Apr 28;11(2). Available from: https://doi.org/10.1128/mBio.03341-19eng
dcterms.referencesVassilopoulou E, Bumbacea RS, Pappa AK, Papadopoulos AN, Bumbacea D. Obesity and Infection: What Have We Learned From the COVID-19 Pandemic. Front Nutr [Internet]. 2022 Jul 22;9. Available from: https://doi.org/10.3389/fnut.2022.931313eng
dcterms.referencesCorrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Front Endocrinol (Lausanne) [Internet]. 2021 Mar 31;12. Available from: https://doi.org/10.3389/fendo.2021.609470eng
dcterms.referencesCariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia [Internet]. 2020 Aug 29;63(8):1500–15. Available from: https://doi.org/10.1007/s00125-020-05180-xeng
oaire.versioninfo:eu-repo/semantics/acceptedVersion
sb.programaEspecialización en Medicina Crítica y Cuidados Intensivosspa
sb.sedeSede Barranquillaspa

Archivos

Bloque original
Mostrando 1 - 2 de 2
Miniatura
Nombre:
PDF_Resumen.pdf
Tamaño:
211.47 KB
Formato:
Adobe Portable Document Format
Descargar
No hay miniatura disponible
Nombre:
PDF.pdf
Tamaño:
502.97 KB
Formato:
Adobe Portable Document Format
Descargar

Colecciones

Especialización

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca